Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Oncotarget
|
November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patients
Sanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
European Urology Oncology
|
March 4, 2024
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, et al.
Journal for Immunotherapy of Cancer
|
February 19, 2026
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
Vicky Makker, Nicoletta Colombo, Antonio Casado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Naoual Menssouri, Loïc Poiraudeau, Carole Helissey, et al.
Cell Death & Disease
|
February 14, 2024
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Cell Death & Disease
|
March 12, 2021
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Cancer Discovery
|
February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.
Cell Death and Differentiation
|
July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Anne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.
Therapeutic Advances in Medical Oncology
|
November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Laia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J Pinato, Lorenza Scotti, Alessandra Gennari, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Oncotarget
|
November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patients
Sanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
European Urology Oncology
|
March 4, 2024
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot, Jonathan Sabio, Loic Poiraudeau, et al.
Journal for Immunotherapy of Cancer
|
February 19, 2026
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
Vicky Makker, Nicoletta Colombo, Antonio Casado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Naoual Menssouri, Loïc Poiraudeau, Carole Helissey, et al.
Cell Death & Disease
|
February 14, 2024
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Cell Death & Disease
|
March 12, 2021
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
François-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.
Cancer Discovery
|
February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.
Cell Death and Differentiation
|
July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Anne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.
Therapeutic Advances in Medical Oncology
|
November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Laia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J Pinato, Lorenza Scotti, Alessandra Gennari, et al.
Page
of 7